2010-2019年住院患者不良事件发生率趋势
该序列横断面研究利用2010-2019年Medicare患者安全监测系统数据,纳入3156家美国急性护理医院244 542例成人住院患者,覆盖急性心肌梗死、心力衰竭、肺炎、重大手术及其他疾病组,从病历摘录21项不良事件指标。结果显示,2010-2019年心肌梗死、心衰、肺炎和重大手术组不良事件率分别从218降至139、168降至116、195降至119、204降至130例/1000出院;其他疾病组2012-2019年粗率维持70例/1000出院不变,但调整后年相对风险0.97(95%CI 0.96-0.99)显著下降。调整后药物不良事件、医院感染和一般不良事件率在所有组均显著下降,重大手术组术后不良事件率亦显著下降。作者认为需进一步研究这些趋势在多大程度上反映患者安全的变化。
要点
- 2010-2019年急性心肌梗死患者不良事件率从218降至139例/1000出院,调整后年相对风险0.94(95%CI 0.93-0.94)。
- 2010-2019年心力衰竭患者不良事件率从168降至116例/1000出院,调整后年相对风险0.95(95%CI 0.94-0.96)。
- 2010-2019年肺炎患者不良事件率从195降至119例/1000出院,调整后年相对风险0.94(95%CI 0.93-0.95)。
- 2010-2019年重大手术患者不良事件率从204降至130例/1000出院,调整后年相对风险0.93(95%CI 0.92-0.94)。
- 其他疾病组2012-2019年粗率维持70例/1000出院不变,调整后年相对风险0.97(95%CI 0.96-0.99)显著下降。
适用人群与场景
- 2010-2019年入住美国3156家急性护理医院的18岁及以上成人患者。
- 纳入4个疾病组:急性心肌梗死(17%)、心力衰竭(17%)、肺炎(21%)、重大手术(22%),以及2012-2019年因所有其他疾病住院的患者(22%)。
研究设计与关键结果
- 研究设计为序列横断面研究,数据来自Medicare患者安全监测系统,纳入244 542例成人住院患者,覆盖3156家美国急性护理医院。
- 4个疾病组共190 286例出院(平均年龄68.0岁,SD 15.9;女性52.6%),其他疾病组54 256例出院(平均年龄57.7岁,SD 20.7;女性59.8%)。
- 2010-2019年急性心肌梗死不良事件率从218降至139例/1000出院,调整后年相对风险0.94(95%CI 0.93-0.94)。
- 2010-2019年心力衰竭不良事件率从168降至116例/1000出院,调整后年相对风险0.95(95%CI 0.94-0.96)。
- 2010-2019年肺炎不良事件率从195降至119例/1000出院,调整后年相对风险0.94(95%CI 0.93-0.95)。
- 2010-2019年重大手术不良事件率从204降至130例/1000出院,调整后年相对风险0.93(95%CI 0.92-0.94)。
- 2012-2019年其他疾病组不良事件率维持70例/1000出院不变,调整后年相对风险0.97(95%CI 0.96-0.99)。
- 调整后药物不良事件、医院感染和一般不良事件率在所有患者组均显著下降;重大手术组术后不良事件调整后率显著下降。
证据类型、等级与局限
- 证据类型:序列横断面研究,数据来自Medicare患者安全监测系统。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Patient safety is a US national priority, yet lacks a comprehensive assessment of progress over the past decade.
OBJECTIVE: To determine the change in the rate of adverse events in hospitalized patients.
DESIGN, SETTING, AND PARTICIPANTS: This serial cross-sectional study used data from the Medicare Patient Safety Monitoring System from 2010 to 2019 to assess in-hospital adverse events in patients. The study included 244 542 adult patients hospitalized in 3156 US acute care hospitals across 4 condition groups from 2010 through 2019: acute myocardial infarction (17%), heart failure (17%), pneumonia (21%), and major surgical procedures (22%); and patients hospitalized from 2012 through 2019 for all other conditions (22%).
EXPOSURES: Adults aged 18 years or older hospitalized during each included calendar year.
MAIN OUTCOMES AND MEASURES: Information on adverse events (abstracted from medical records) included 21 measures across 4 adverse event domains: adverse drug events, hospital-acquired infections, adverse events after a procedure, and general adverse events (hospital-acquired pressure ulcers and falls). The outcomes were the total change over time for the observed and risk-adjusted adverse event rates in the subpopulations.
RESULTS: The study sample included 190 286 hospital discharges combined in the 4 condition-based groups of acute myocardial infarction, heart failure, pneumonia, and major surgical procedures (mean age, 68.0 [SD, 15.9] years; 52.6% were female) and 54 256 hospital discharges for the group including all other conditions (mean age, 57.7 [SD, 20.7] years; 59.8% were female) from 3156 acute care hospitals across the US. From 2010 to 2019, the total change was from 218 to 139 adverse events per 1000 discharges for acute myocardial infarction, from 168 to 116 adverse events per 1000 discharges for heart failure, from 195 to 119 adverse events per 1000 discharges for pneumonia, and from 204 to 130 adverse events per 1000 discharges for major surgical procedures. From 2012 to 2019, the rate of adverse events for all other conditions remained unchanged at 70 adverse events per 1000 discharges. After adjustment for patient and hospital characteristics, the annual change represented by relative risk in all adverse events per 1000 discharges was 0.94 (95% CI, 0.93-0.94) for acute myocardial infarction, 0.95 (95% CI, 0.94-0.96) for heart failure, 0.94 (95% CI, 0.93-0.95) for pneumonia, 0.93 (95% CI, 0.92-0.94) for major surgical procedures, and 0.97 (95% CI, 0.96-0.99) for all other conditions. The risk-adjusted adverse event rates declined significantly in all patient groups for adverse drug events, hospital-acquired infections, and general adverse events. For patients in the major surgical procedures group, the risk-adjusted rates of events after a procedure declined significantly.
CONCLUSIONS AND RELEVANCE: In the US between 2010 and 2019, there was a significant decrease in the rates of adverse events abstracted from medical records for patients admitted for acute myocardial infarction, heart failure, pneumonia, and major surgical procedures and there was a significant decrease in the adjusted rates of adverse events between 2012 and 2019 for all other conditions. Further research is needed to understand the extent to which these trends represent a change in patient safety.
参考来源
- Eldridge N, Wang Y, Metersky M, et al. Trends in Adverse Event Rates in Hospitalized Patients, 2010-2019. JAMA. 2022. PMID: 35819424. doi:10.1001/jama.2022.9600
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。